Rothschild Investment LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Rothschild Investment LLC’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.42K	Sell	1,763 -21	-1%	-$81	﹤0.01%	2053
2026 Q1	$6.26K	Buy	1,784 +818	+85%	+$3.35K	﹤0.01%	1944
2025 Q4	$3.25K	Buy	966 +46	+5%	+$119	﹤0.01%	2116
2025 Q3	$1.21K	Buy	+920	New	+$952	﹤0.01%	2507
2025 Q2	–	Sell	-725	Closed	-$1.07K	–	3109
2025 Q1	$1.07K	Buy	725 +470	+184%	+$1.12K	﹤0.01%	2301
2024 Q4	$1.13K	Buy	255 +155	+155%	+$629	﹤0.01%	2143
2024 Q3	$412	Buy	100 +65	+186%	+$349	﹤0.01%	2516
2024 Q2	$228	Buy	35 +20	+133%	+$141	﹤0.01%	2442
2024 Q1	$131	Buy	+15	New	+$182	﹤0.01%	2026

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Rothschild Investment LLC's IRWD Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Ironwood Pharmaceuticals (IRWD) stake by 1.2% in Q2 2026, selling an estimated $81 and leaving 1,763 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Rothschild Investment LLC first reported a position in IRWD in Q1 2024 and has held it in 9 quarters since. 71 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Rothschild Investment LLC held 1,763 shares of Ironwood Pharmaceuticals worth $7.42K as of Q2 2026.
Rothschild Investment LLC sold 21 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $81.
Ironwood Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2053 holding.
Rothschild Investment LLC first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
71 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.